Caplin Point Laboratories (CAPLIPOINT) Share Price Falls 2.08% Today
- September 29, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price fell on 29 September 2026, with the stock ending at Rs 2793.3, down 2.08% from the previous close of Rs 2852.7. The company’s market capitalisation stood at Rs 21,555.4 crore, placing Caplin Point Laboratories in the Large Cap category. The move makes Caplin Point Laboratories Stock News relevant for investors tracking Caplin Point Laboratories Share Price Today because the session combined a lower close with a day’s range that stayed close to the low of the session. The supplied data confirms the price event, but it does not establish a company-specific catalyst. In that context, Univest is following the move with a focus on verified price action, valuation, sector comparison and the current market setup around Caplin Point Laboratories Share Price.
Caplin Point Laboratories (CAPLIPOINT) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,793.3 |
| Previous Close | Rs 2,852.7 |
| Today's Move | -Rs 59.40 (-2.08%) |
| Open | Rs 2,863.4 |
| High | Rs 2,867 |
| Low | Rs 2,788.9 |
| Turnover | Rs 0.71 crore |
| Market Capitalisation | Rs 21,555.4 crore |
| Market Cap Category | Large Cap |
Caplin Point Laboratories Share Price Today showed a clear session-wise decline. The stock opened at Rs 2863.4, moved to an intraday high of Rs 2867 and a low of Rs 2788.9, before closing at Rs 2793.3. That leaves the stock Rs 59.4 below the previous close of Rs 2852.7, or 2.08% lower on the day. The gap between the open and close shows that the session finished well below the opening level, while the day’s low sat only slightly beneath the closing price. Turnover was Rs 0.71 crore. As the company sits in the Large Cap category, Caplin Point Laboratories Share Price drew attention for a same-day decline rather than for a change in long-term business structure. The data confirms the move in Caplin Point Laboratories Stock News, but it does not identify a specific company event behind the fall. That makes the next lens for Caplin Point Laboratories Share Price the broader combination of fundamentals and sector comparison.
Caplin Point Laboratories (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 21,555.4 crore |
| P/E Ratio | 32.59x |
| P/B Ratio | 5.9x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.28% |
Caplin Point Laboratories has a market capitalisation of Rs 21,555.40 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.59x, P/B at 5.9x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.28%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.59x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 5.9x |
| Benchmark Median P/B | 2.88x |
| Benchmark Average P/B | 4.34x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 21,555.4 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
| Benchmark Average Market Cap | Rs 14,389.26 crore |
Caplin Point Laboratories operates in Healthcare, within Pharmaceuticals & Drugs, and the same-industry benchmark covers 199 companies. In that universe, Caplin Point Laboratories Share Price can be compared with a company P/E of 32.59 versus the benchmark median of 32.59 and average of 49. The industry range is wide, with a minimum P/E of 3.46 and a maximum of 707.31, so the stock sits exactly at the median on the supplied data. On valuation, the company P/B of 5.9 is above the benchmark median of 2.88 and the benchmark average of 4.34. ROE at 20.79% is above the benchmark median of 11.7% and average of 10.68%, while ROCE at 24.97% is also above the benchmark median of 13.61% and average of 13.4%. The sector snapshot also shows market-cap reference points across the same industry, with a median of Rs 783.26 crore and an average of Rs 14,389.26 crore. Against that backdrop, Caplin Point Laboratories Market Cap of Rs 21,555.4 crore is above the industry average and well above the median. For Caplin Point Laboratories Stock News, this sector context shows that today’s decline sits inside a broader valuation framework, not in isolation.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Caplin Point Laboratories Share Price can also be read against listed peers in the same industry. On market capitalisation, Caplin Point Laboratories at Rs 21,555.4 crore is below Sun Pharmaceutical Industries at Rs 4,44,716.74 crore, Divi’s Laboratories at Rs 2,55,115.31 crore and Torrent Pharmaceuticals at Rs 1,89,613.38 crore, but above Zydus Lifesciences at Rs 1,19,899.96 crore and Cipla at Rs 1,12,875.68 crore. On P/E, Caplin Point Laboratories Share Price sits at 32.59, lower than Sun Pharmaceutical’s 36.5, Divi’s Laboratories’ 86.51, Torrent Pharmaceuticals’ 84.92 and Laurus Labs at 99.43 in the broader peer set, while above Zydus Lifesciences’ 26.79. ROE of 20.79% is ahead of Sun Pharmaceutical, Divi’s Laboratories, Zydus Lifesciences and Cipla, though below Torrent Pharmaceuticals and Lupin ROCE at 24.97% is ahead of Sun Pharmaceutical, Divi’s Laboratories, Zydus Lifesciences and Cipla, but below Lupin’s 28.86% and Torrent Pharmaceuticals’ 19.27% appears lower than Caplin Point Laboratories on the supplied numbers? No, it is lower, so Caplin Point Laboratories stands above that peer on ROCE. In Caplin Point Laboratories Stock News, the peer set shows a mix of higher and lower valuation profiles rather than a one-sided comparison.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price closed at Rs 2793.3, down 2.08% from Rs 2852.7.
- The stock traded between Rs 2867 and Rs 2788.9 during the session.
- Turnover stood at Rs 0.71 crore for the day.
- Market capitalisation was Rs 21,555.4 crore, placing the company in the Large Cap category.
- P/E was 32.59, P/B was 5.9, ROE was 20.79% and ROCE was 24.97%.
About Caplin Point Laboratories
Caplin Point Laboratories is part of Healthcare and operates in Pharmaceuticals & Drugs. The stock is tracked on both NSE and BSE, and Caplin Point Laboratories Share Price is followed for its mix of market capitalisation, valuation and profitability metrics. The company’s reported financial markers include EPS of Rs 87.53, book value of Rs 483.17 and dividend yield of 0.28%. Univest keeps Caplin Point Laboratories Stock Analysis in view alongside sector and peer comparisons so readers can place today’s move in a wider context. For Caplin Point Laboratories Share Price Live tracking, the company’s current market position is often assessed through the same set of disclosed financial ratios and industry benchmarks.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories (CAPLIPOINT) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Track Caplin Point Laboratories Share Price on Univest for live updates, market cap context, P/E, P/B, ROE, ROCE, EPS, book value, dividend yield, shareholding pattern, 52-week levels and market insights. Univest presents Caplin Point Laboratories Share Price Today in a format built for quick comparison and deeper research.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Caplin Point Laboratories Share Price fall today?
Ans. The stock fell 2.08% to Rs 2793.3 from Rs 2852.7. The supplied data confirms the move, but it does not establish a company-specific catalyst behind Caplin Point Laboratories Share Price today.
What was the day’s price range for Caplin Point Laboratories Share Price?
Ans. Caplin Point Laboratories traded between Rs 2788.9 and Rs 2867 today. It opened at Rs 2863.4 and closed at Rs 2793.3, which leaves the session ending near the lower end of the day’s range.
What is the market capitalisation of Caplin Point Laboratories?
Ans. Caplin Point Laboratories has a market capitalisation of Rs 21,555.4 crore. That places it in the Large Cap category and above the same-industry market-cap median of Rs 783.26 crore. The company operates in the Healthcare sector.
How does Caplin Point Laboratories look on valuation?
Ans. Caplin Point Laboratories Share Price is backed by a P/E of 32.59 and a P/B of 5.9. In its industry benchmark, the P/E matches the median, while the P/B is above the median and average.
How do ROE and ROCE compare for Caplin Point Laboratories?
Ans. The company reports ROE of 20.79% and ROCE of 24.97%. Both measures stand above the same-industry benchmark median and average, which gives useful context to Caplin Point Laboratories Share Price today.
